Clinical trial
Novel Imaging of Lymph Nodes in Patients With Rectal Cancer Using Ferumoxytol Enhanced MRI
NCT03280277 is registered in ClinicalTrials.gov with OHSU Knight Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Novel Imaging of Lymph Nodes in Patients With Rectal Cancer Using Ferumoxytol Enhanced MRI
- Lead sponsor
- OHSU Knight Cancer Institute
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- April 27, 2018
- Completion date
- August 26, 2021
- Enrollment
- 2 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
locally advanced rectal carcinoma, stage iii rectal cancer ajcc v7, stage iiia rectal cancer ajcc v7, stage iiib rectal cancer ajcc v7, stage iiic rectal cancer ajcc v7